oral glp 1 agonist for type 2 diabetes Orforglipron, an Small-Molecule GLP-1 Receptor Obesity November 5, 2025 DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied Oral GLP-1 receptor agonists: competition

In a meta-analysis with six studies (three liraglutide studies, three exenatide studies), treatment of GLP-1RAs produced significant improvements in liver histology such as lobular inflammation, hepatocellular ballooning, and fibrosis [78]

More than half (52%) of GLP-1 users described their eating habits as "mindful", saying they are increasingly guided by hunger cues rather than established routines or restrictive dieting practices

Leaderboards that refresh frequently, achievement badges, and gentle nudges about newly released titles keep the experience feeling current without being pushy

23872394, May 2014, doi: 10.2174/13816128113199990474

Curr Med Res Opin 24(1):275286

Boirie Y, Guillet C